Trial Profile
A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2019
Price :
$35
*
At a glance
- Drugs Belatacept (Primary) ; Antithymocyte globulin; Methylprednisolone; Mycophenolate mofetil; Prednisone; Tacrolimus; Tacrolimus
- Indications Lung transplant rejection
- Focus Therapeutic Use
- 31 Oct 2019 Status changed from not yet recruiting to recruiting.
- 17 Oct 2019 Planned End Date changed from 30 Apr 2021 to 30 Apr 2022.
- 17 Oct 2019 Planned primary completion date changed from 31 Jan 2021 to 1 Feb 2022.